Connection

CHERYL WALKER to Tumor Suppressor Proteins

This is a "connection" page, showing publications CHERYL WALKER has written about Tumor Suppressor Proteins.
Connection Strength

3.224
  1. Differential localization of ATM is correlated with activation of distinct downstream signaling pathways. Cell Cycle. 2010 Sep 15; 9(18):3685-6.
    View in: PubMed
    Score: 0.272
  2. ATM engages the TSC2/mTORC1 signaling node to regulate autophagy. Autophagy. 2010 Jul; 6(5):672-3.
    View in: PubMed
    Score: 0.268
  3. ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS. Proc Natl Acad Sci U S A. 2010 Mar 02; 107(9):4153-8.
    View in: PubMed
    Score: 0.262
  4. Carboxy terminal tail of polycystin-1 regulates localization of TSC2 to repress mTOR. PLoS One. 2010 Feb 16; 5(2):e9239.
    View in: PubMed
    Score: 0.262
  5. PTEN deficiency is fully penetrant for prostate adenocarcinoma in C57BL/6 mice via mTOR-dependent growth. Am J Pathol. 2009 May; 174(5):1869-79.
    View in: PubMed
    Score: 0.248
  6. AMP-activated protein kinase signaling results in cytoplasmic sequestration of p27. Cancer Res. 2008 Aug 15; 68(16):6496-506.
    View in: PubMed
    Score: 0.236
  7. Loss of tuberous sclerosis complex-2 function and activation of mammalian target of rapamycin signaling in endometrial carcinoma. Clin Cancer Res. 2008 May 01; 14(9):2543-50.
    View in: PubMed
    Score: 0.231
  8. Identification of a sensitive period for developmental programming that increases risk for uterine leiomyoma in Eker rats. Reprod Sci. 2007 Feb; 14(2):121-36.
    View in: PubMed
    Score: 0.212
  9. Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning. J Cell Biol. 2006 Apr 24; 173(2):279-89.
    View in: PubMed
    Score: 0.201
  10. TSC2, a key player in tumor suppression and cystic kidney disease. Nephrol Ther. 2006 Jan; 2 Suppl 2:S119-22.
    View in: PubMed
    Score: 0.197
  11. Interaction between genetic susceptibility and early-life environmental exposure determines tumor-suppressor-gene penetrance. Proc Natl Acad Sci U S A. 2005 Jun 14; 102(24):8644-9.
    View in: PubMed
    Score: 0.189
  12. Lycopene in the prevention of renal cell cancer in the TSC2 mutant Eker rat model. Arch Biochem Biophys. 2015 Apr 15; 572:36-39.
    View in: PubMed
    Score: 0.092
  13. A tuberous sclerosis complex signalling node at the peroxisome regulates mTORC1 and autophagy in response to ROS. Nat Cell Biol. 2013 Oct; 15(10):1186-96.
    View in: PubMed
    Score: 0.083
  14. Reactive nitrogen species regulate autophagy through ATM-AMPK-TSC2-mediated suppression of mTORC1. Proc Natl Acad Sci U S A. 2013 Aug 06; 110(32):E2950-7.
    View in: PubMed
    Score: 0.083
  15. Loss of inhibitory insulin receptor substrate-1 phosphorylation: An early event in endometrial hyperplasia and progression to carcinoma. Cell Cycle. 2010 Jul 15; 9(14):2698-9.
    View in: PubMed
    Score: 0.067
  16. Estrogen promotes the survival and pulmonary metastasis of tuberin-null cells. Proc Natl Acad Sci U S A. 2009 Feb 24; 106(8):2635-40.
    View in: PubMed
    Score: 0.061
  17. Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene. Cancer Res. 2003 May 15; 63(10):2675-80.
    View in: PubMed
    Score: 0.041
  18. Polycystic kidney disease as a result of loss of the tuberous sclerosis 2 tumor suppressor gene during development. Am J Pathol. 2003 Feb; 162(2):457-68.
    View in: PubMed
    Score: 0.040
  19. 14-3-3 interacts with the tumor suppressor tuberin at Akt phosphorylation site(s). Cancer Res. 2002 Nov 15; 62(22):6475-80.
    View in: PubMed
    Score: 0.040
  20. Retention of membrane-localized beta-catenin in cells lacking functional polycystin-1 and tuberin. Mol Carcinog. 2002 Mar; 33(3):131-6.
    View in: PubMed
    Score: 0.038
  21. Ral and Rheb GTPase activating proteins integrate mTOR and GTPase signaling in aging, autophagy, and tumor cell invasion. Mol Cell. 2014 Jan 23; 53(2):209-20.
    View in: PubMed
    Score: 0.021
  22. Lymphangioleiomyomatosis and TSC2-/- cells. Lymphat Res Biol. 2010 Mar; 8(1):59-69.
    View in: PubMed
    Score: 0.016
  23. Loss of inhibitory insulin receptor substrate-1 phosphorylation is an early event in mammalian target of rapamycin-dependent endometrial hyperplasia and carcinoma. Cancer Prev Res (Phila). 2010 Mar; 3(3):290-300.
    View in: PubMed
    Score: 0.016
  24. Tuberin, the tuberous sclerosis complex 2 tumor suppressor gene product, regulates Rho activation, cell adhesion and migration. Oncogene. 2002 Dec 05; 21(55):8470-6.
    View in: PubMed
    Score: 0.010
  25. Cell proliferation is insufficient, but loss of tuberin is necessary, for chemically induced nephrocarcinogenicity. Am J Physiol Renal Physiol. 2002 Aug; 283(2):F262-70.
    View in: PubMed
    Score: 0.010
  26. Aberrant expression of HMGA2 in uterine leiomyoma associated with loss of TSC2 tumor suppressor gene function. Cancer Res. 2002 Jul 01; 62(13):3766-72.
    View in: PubMed
    Score: 0.010
  27. Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation. A role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM). J Biol Chem. 2002 Aug 23; 277(34):30958-67.
    View in: PubMed
    Score: 0.010
  28. Phosphatidylinositol 3-kinase but not tuberin is required for PDGF-induced cell migration. Am J Physiol Lung Cell Mol Physiol. 2002 Apr; 282(4):L854-62.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.